J. López-Martin

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

J. Tabernero, T. Yap, D. Olmos, 2012, British Journal of Cancer.